Ireland pharmaceutical exports
How much medicine Ireland ships each month, where it goes, and how factory output is moving, from the Central Statistics Office's own tables.
Ireland exported €6.9bn of medicinal and pharmaceutical products in July 2026, +0.3% on the same month a year earlier, according to the CSO's goods trade figures. Over the last 12 months the total was €90.1bn, 41.8% of everything Ireland exported in goods, with 44% going to USA. These are customs-based goods values (SITC 54); the CSO revises the most recent months in later releases, and comparisons with 2025 are affected by the exceptionally large shipments in the first half of that year, visible in the monthly table.
Pharma exports by month
last 5 yearsMonthly value of exports, SITC 54, euro billion (CSO table TSM09).
| Month | Pharma exports | Change on a year earlier | Share of goods exports | Pharma imports |
|---|---|---|---|---|
| July 2026 | €6.88bn | +0.3% | 36.4% | €1.99bn |
| June 2026 | €6.66bn | -7.0% | 36.4% | €1.85bn |
| May 2026 | €5.61bn | -58.6% | 32.9% | €1.78bn |
| April 2026 | €7.77bn | -28.2% | 41.7% | €1.79bn |
| March 2026 | €7.03bn | -70.1% | 38.7% | €1.83bn |
| February 2026 | €5.81bn | -63.8% | 37.6% | €1.94bn |
| January 2026 | €5.89bn | -61.4% | 37.4% | €1.87bn |
| December 2025 | €5.99bn | -3.8% | 37.9% | €1.29bn |
| November 2025 | €6.54bn | -40.6% | 40.4% | €2.16bn |
| October 2025 | €6.94bn | -36.9% | 42.1% | €1.69bn |
| September 2025 | €18.51bn | +72.2% | 64.5% | €1.32bn |
| August 2025 | €6.48bn | -21.0% | 40.4% | €1.71bn |
| July 2025 | €6.86bn | -3.3% | 40.8% | €2.50bn |
| June 2025 | €7.16bn | +7.4% | 42.3% | €1.97bn |
| May 2025 | €13.55bn | +72.1% | 58.3% | €1.87bn |
| April 2025 | €10.82bn | +22.9% | 50.7% | €1.82bn |
| March 2025 | €23.50bn | +242.2% | 62.6% | €2.65bn |
| February 2025 | €16.04bn | +153.4% | 64.2% | €2.03bn |
| January 2025 | €15.24bn | +72.6% | 61.2% | €1.76bn |
| December 2024 | €6.23bn | +7.6% | 39.6% | €1.13bn |
| November 2024 | €11.01bn | +63.3% | 53.3% | €1.61bn |
| October 2024 | €11.00bn | +47.6% | 51.9% | €2.10bn |
| September 2024 | €10.75bn | +78.3% | 48.2% | €1.44bn |
| August 2024 | €8.20bn | +19.9% | 47.2% | €1.83bn |
| July 2024 | €7.10bn | +2.3% | 38.9% | €1.33bn |
| June 2024 | €6.67bn | -5.0% | 39.8% | €1.16bn |
| May 2024 | €7.87bn | +22.2% | 43.6% | €1.16bn |
| April 2024 | €8.80bn | +65.7% | 45.3% | €0.89bn |
| March 2024 | €6.87bn | -4.8% | 35.8% | €0.96bn |
| February 2024 | €6.33bn | +12.9% | 39.7% | €1.09bn |
| January 2024 | €8.83bn | +45.1% | 46.7% | €1.01bn |
| December 2023 | €5.79bn | +8.8% | 42.0% | €0.85bn |
| November 2023 | €6.74bn | -1.0% | 42.0% | €1.46bn |
| October 2023 | €7.46bn | +13.3% | 42.6% | €1.36bn |
| September 2023 | €6.03bn | -8.0% | 38.0% | €0.92bn |
| August 2023 | €6.84bn | +5.8% | 42.5% | €1.01bn |
Share of goods exports = pharma exports divided by total merchandise exports for the same month (both from TSM09). Download the full monthly series as CSV (from January 2015).
Pharma exports by year
since 2015* 2026 covers 7 months to July 2026. Annual sums of the monthly values in TSM09, calculated by Priya Life Science.
| Year | Pharma exports | Change | Share of goods exports | Pharma imports |
|---|---|---|---|---|
| 2026 7 months |
€45.6bn | — | 37.3% | €13.1bn |
| 2025 | €137.6bn | +38.1% | 53.2% | €22.8bn |
| 2024 | €99.7bn | +28.6% | 44.5% | €15.7bn |
| 2023 | €77.5bn | -3.4% | 39.5% | €12.7bn |
| 2022 | €80.2bn | +28.0% | 38.4% | €11.6bn |
| 2021 | €62.7bn | +0.9% | 37.8% | €9.5bn |
| 2020 | €62.1bn | +25.4% | 38.3% | €8.4bn |
| 2019 | €49.5bn | +7.2% | 32.5% | €7.1bn |
| 2018 | €46.2bn | +30.3% | 32.8% | €11.3bn |
| 2017 | €35.5bn | +17.5% | 28.9% | €8.8bn |
| 2016 | €30.2bn | -0.2% | 25.3% | €6.2bn |
| 2015 | €30.2bn | — | 26.9% | €5.8bn |
Where Ireland's pharma exports go
last 12 monthsExports of SITC 54 by country of destination, sum of the last 12 months (CSO table TSM10).
By area over the same 12 months: EU 27 €37.8bn (42%), United Kingdom €3.3bn, all countries outside the EU €52.3bn (58%). The country list is the CSO's published breakdown; small markets are grouped as "other".
| Destination | Last 12 months | Previous 12 months | Change | Share |
|---|---|---|---|---|
| USA | €39.57bn | €82.03bn | -51.8% | 43.9% |
| Netherlands | €15.24bn | €16.02bn | -4.8% | 16.9% |
| Belgium | €9.56bn | €13.13bn | -27.2% | 10.6% |
| Germany | €5.35bn | €7.28bn | -26.6% | 5.9% |
| Great Britain | €2.67bn | €1.18bn | +126.6% | 3.0% |
| Italy | €2.61bn | €5.17bn | -49.5% | 2.9% |
| China | €2.38bn | €1.83bn | +30.1% | 2.6% |
| France | €1.85bn | €2.21bn | -16.1% | 2.1% |
| Japan | €1.56bn | €1.30bn | +19.8% | 1.7% |
| Switzerland | €1.35bn | €2.52bn | -46.3% | 1.5% |
| Spain | €1.07bn | €962m | +11.1% | 1.2% |
| Northern Ireland | €591m | €625m | -5.5% | 0.7% |
| Australia | €565m | €397m | +42.4% | 0.6% |
| Brazil | €403m | €352m | +14.4% | 0.4% |
| Saudi Arabia | €354m | €232m | +52.5% | 0.4% |
| Canada | €347m | €496m | -30.1% | 0.4% |
| Hungary | €293m | €224m | +30.8% | 0.3% |
| Sweden | €285m | €225m | +26.5% | 0.3% |
| Poland | €257m | €249m | +3.1% | 0.3% |
| Greece | €254m | €122m | +107.6% | 0.3% |
| Turkey | €252m | €184m | +36.9% | 0.3% |
| Portugal | €234m | €682m | -65.7% | 0.3% |
| Mexico | €225m | €330m | -31.9% | 0.2% |
| Russia | €224m | €201m | +11.4% | 0.2% |
| Taiwan | €217m | €157m | +38.1% | 0.2% |
| South Korea | €184m | €284m | -35.2% | 0.2% |
| Singapore | €180m | €221m | -18.6% | 0.2% |
| Czech Republic | €154m | €85m | +81.2% | 0.2% |
| Austria | €143m | €176m | -18.7% | 0.2% |
| Romania | €136m | €103m | +32.1% | 0.2% |
| Malaysia | €129m | €62m | +109.8% | 0.1% |
| Slovenia | €94m | €95m | -0.8% | 0.1% |
| Denmark | €60m | €62m | -3.8% | 0.1% |
| Slovakia | €58m | €34m | +68.6% | 0.1% |
| Other countries | €931m | €866m | +7.5% | 1.0% |
Destinations with at least €50 million in the last 12 months. Values are the country of destination as known when the goods leave Ireland, so goods routed through hubs (for example the Netherlands and Belgium) may be recorded there. "Other countries" groups destinations the CSO does not list separately.
Factory output: the modern sector versus the rest
index, 2021 = 100Industrial Production Index, seasonally adjusted, base year 2021 = 100 (CSO table MIM05).
| Month | Modern sector | All manufacturing | Traditional sector | Modern sector, change on a year earlier |
|---|---|---|---|---|
| August 2026 | 115.7 | 113.0 | 115.5 | -18.1% |
| July 2026 | 117.8 | 116.7 | 110.5 | +1.2% |
| June 2026 | 115.4 | 114.9 | 114.2 | -1.2% |
| May 2026 | 115.0 | 114.3 | 107.6 | -14.4% |
| April 2026 | 115.2 | 114.5 | 110.2 | -2.9% |
| March 2026 | 112.7 | 112.5 | 108.0 | -25.6% |
| February 2026 | 112.0 | 112.5 | 111.3 | -13.3% |
| January 2026 | 105.6 | 106.8 | 110.8 | -9.7% |
| December 2025 | 119.2 | 119.2 | 111.7 | +5.7% |
| November 2025 | 115.5 | 118.1 | 110.4 | +11.3% |
| October 2025 | 118.1 | 118.8 | 116.9 | +10.2% |
| September 2025 | 113.7 | 115.9 | 114.4 | +10.9% |
| August 2025 | 141.2 | 133.8 | 109.2 | +33.3% |
| July 2025 | 116.4 | 116.5 | 114.4 | +10.9% |
| June 2025 | 116.8 | 115.5 | 114.1 | +13.6% |
| May 2025 | 134.4 | 131.2 | 116.7 | +41.0% |
| April 2025 | 118.7 | 118.2 | 118.7 | +19.2% |
| March 2025 | 151.5 | 145.8 | 119.4 | +60.8% |
| February 2025 | 129.2 | 127.4 | 112.1 | +46.7% |
| January 2025 | 117.0 | 117.0 | 113.2 | +20.6% |
| December 2024 | 112.8 | 112.9 | 122.6 | +7.3% |
| November 2024 | 103.8 | 108.1 | 113.6 | -4.9% |
| October 2024 | 107.2 | 109.4 | 118.1 | +17.0% |
| September 2024 | 102.5 | 105.7 | 119.2 | +2.7% |
The CSO does not publish a pharmaceuticals-only monthly production index (the NACE 21 line is suppressed for confidentiality). The "modern sector" it publishes instead groups pharmaceuticals (NACE 21) with chemicals (20), computers and electronics (26), electrical equipment (27), medical and dental instruments (325) and reproduction of recorded media (182); the "traditional sector" covers the remaining manufacturing industries plus mining and quarrying (05 to 09) and energy supply (35). Month-to-month swings in the modern sector are large; because the pharmaceuticals line is suppressed, how much of them comes from pharmaceuticals cannot be read from these figures.
What these figures are. Trade values are the CSO's customs-based merchandise trade statistics for SITC division 54, medicinal and pharmaceutical products, in current euro. They do not include services, royalties or intellectual-property flows, and active ingredients classified as organic chemicals (SITC 51) are outside this division. The CSO publishes the latest months as preliminary and revises them in later releases; this page shows whatever the CSO publishes at the time of the last sync. 12-month totals, annual sums, shares and percentage changes are calculated by Priya Life Science from those published values.
How this page is built
Every monthly value is the CSO's published figure, re-used under the CSO's Creative Commons Attribution 4.0 licence. The 12-month totals, annual sums, shares and percentage changes are calculated here from those values and labelled as such.
- CSO Ireland, Goods Exports and Imports, table TSM09 ↗ monthly value of exports and imports by commodity group (SITC 54 and total) and area, euro thousand
- CSO Ireland, Goods Exports and Imports, table TSM10 ↗ monthly value of exports of SITC 54 by country of destination
- CSO Ireland, Industrial Production and Turnover, table MIM05 ↗ monthly industrial production index by sector, base 2021 = 100, raw and seasonally adjusted
A job queries the CSO's PxStat API for the three tables after each monthly release and stores the series. No AI drafting and no editorial pass. See our editorial standards. The the CSO data on this page was last retrieved on 10 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.